Detailed answers about PETER MOSS LEUKAEMIA MEDTECH RESEARCH CIC, including incorporation, status, business activity, and accounts information.
When was PETER MOSS LEUKAEMIA MEDTECH RESEARCH CIC founded?
PETER MOSS LEUKAEMIA MEDTECH RESEARCH CIC was officially incorporated on 17 November 2021 and is registered under company number 13748398. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is PETER MOSS LEUKAEMIA MEDTECH RESEARCH CIC?
Community Interest Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of PETER MOSS LEUKAEMIA MEDTECH RESEARCH CIC?
PETER MOSS LEUKAEMIA MEDTECH RESEARCH CIC's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does PETER MOSS LEUKAEMIA MEDTECH RESEARCH CIC do?
PETER MOSS LEUKAEMIA MEDTECH RESEARCH CIC operates in the following sectors: 62012 - Business and domestic software development, 72190 - Other research and experimental development on natural sciences and engineering. These SIC codes provide insight into the company's business activities and industry focus.
What is PETER MOSS LEUKAEMIA MEDTECH RESEARCH CIC's registered address?
The registered office address of PETER MOSS LEUKAEMIA MEDTECH RESEARCH CIC is SECOND FLOOR, KIRKLAND HOUSE, 11-15 PETERBOROUGH ROAD, HARROW, MIDDLESEX, UNITED KINGDOM, HA1 2AX. This is the official address filed with Companies House for legal and statutory correspondence.
Is PETER MOSS LEUKAEMIA MEDTECH RESEARCH CIC financially stable?
The most recent accounts for PETER MOSS LEUKAEMIA MEDTECH RESEARCH CIC were made up to 30 November 2024, filed as DORMANT. Next accounts are due by 31 August 2026.